Veterinary Medicines

CANIGEN L SUSPENSION FOR INJECTION FOR DOGS

Authorised
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Download as PDF

Product identification

Medicine name:
CANIGEN L SUSPENSION FOR INJECTION FOR DOGS
Virbagen canis L
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
    4350.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    4250.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Plastic box of 1 vial containing 1 ml of suspension
  • Plastic box of 100 vials containing 1 ml of suspension
  • Plastic box of 50 vials containing 1 ml of suspension
  • Plastic box of 25 vials containing 1 ml of suspension
  • Plastic box of 10 vials containing 1 ml of suspension
  • Cardboard box of 1 vial containing 1 ml of suspension
  • Cardboard box of 100 vials containing 1 ml of suspension
  • Cardboard box of 50 vials containing 1 ml of suspension
  • Cardboard box of 25 vials containing 1 ml of suspension
  • Cardboard box of 10 vials containing 1 ml of suspension

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11853.01.1
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0310/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/05/2024
Download